Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

593 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High-dose atomoxetine treatment of ADHD in youths with limited response to standard doses.
Kratochvil CJ, Michelson D, Newcorn JH, Weiss MD, Busner J, Moore RJ, Ruff DD, Ramsey J, Dickson R, Turgay A, Saylor KE, Luber S, Vaughan B, Allen AJ; ATOMOXETINE HIGH-DOSE STUDY GROUP. Kratochvil CJ, et al. Among authors: moore rj. J Am Acad Child Adolesc Psychiatry. 2007 Sep;46(9):1128-1137. doi: 10.1097/chi.0b013e318074eeb3. J Am Acad Child Adolesc Psychiatry. 2007. PMID: 17712236 Clinical Trial.
Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response.
Newcorn JH, Kratochvil CJ, Allen AJ, Casat CD, Ruff DD, Moore RJ, Michelson D; Atomoxetine/Methylphenidate Comparative Study Group. Newcorn JH, et al. Among authors: moore rj. Am J Psychiatry. 2008 Jun;165(6):721-30. doi: 10.1176/appi.ajp.2007.05091676. Epub 2008 Feb 15. Am J Psychiatry. 2008. PMID: 18281409 Clinical Trial.
Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders.
Wilens TE, Adler LA, Weiss MD, Michelson D, Ramsey JL, Moore RJ, Renard D, Brady KT, Trzepacz PT, Schuh LM, Ahrbecker LM, Levine LR; Atomoxetine ADHD/SUD Study Group. Wilens TE, et al. Among authors: moore rj. Drug Alcohol Depend. 2008 Jul 1;96(1-2):145-54. doi: 10.1016/j.drugalcdep.2008.02.009. Epub 2008 Apr 9. Drug Alcohol Depend. 2008. PMID: 18403134 Clinical Trial.
Abuse liability assessment of atomoxetine in a drug-abusing population.
Jasinski DR, Faries DE, Moore RJ, Schuh LM, Allen AJ. Jasinski DR, et al. Among authors: moore rj. Drug Alcohol Depend. 2008 May 1;95(1-2):140-6. doi: 10.1016/j.drugalcdep.2008.01.008. Epub 2008 Mar 6. Drug Alcohol Depend. 2008. PMID: 18328639 Clinical Trial.
Advancing disability-inclusive climate research and action, climate justice, and climate-resilient development.
Stein PJS, Stein MA, Groce N, Kett M, Akyeampong EK, Alford WP, Chakraborty J, Daniels-Mayes S, Eriksen SH, Fracht A, Gallegos L, Grech S, Gurung P, Hans A, Harpur P, Jodoin S, Lord JE, Macanawai SS, McClain-Nhlapo CV, Mezmur BD, Moore RJ, Muñoz Y, Patel V, Pham PN, Quinn G, Sadlier SA, Shachar C, Smith MS, Van Susteren L. Stein PJS, et al. Among authors: moore rj. Lancet Planet Health. 2024 Apr;8(4):e242-e255. doi: 10.1016/S2542-5196(24)00024-X. Lancet Planet Health. 2024. PMID: 38580426 Free article. Review.
593 results